FDA eases concern about certain diabetes drugs

HealthBeat Medicare Diabetes

People who take Januvia, Byetta (BY’-yet-uh) or certain other widely prescribed medicines for diabetes can breathe a little easier. U.S. and European regulators say they have found no compelling evidence of a link between these drugs and pancreas problems.

The federal Food and Drug Administration and its European counterpart started reviews last year of these medicines after a study suggested a safety concern. They include Janumet, Victoza, Bydureon and other brands. The drugs help spur insulin production after meals, to help people with Type 2 diabetes break down carbohydrates in food.

In an article in Wednesday’s New England Journal of Medicine, FDA and European scientists say their review provides reassurance but that a final conclusion has not been reached and they will continue to investigate concerns.

KSN.com provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others. If you see an inappropriate comment, please flag it for our moderators to review.

blog comments powered by Disqus